Blogs@BJUI

Digital Doctor Conference 2013

/
Digital consumerism is progressing relentlessly and whilst the advantages of new technology are evident in our personal lives, there is a palpable air of concern amongst the medical profession. “The Digital Doctor” team are positively embracing the benefits of moving healthcare into a new era and hope to direct the use of new technology in a constructive manner that will benefit both healthcare professionals and patients. To achieve these aims the “Digital Doctor Conference 2013”, was held…

Out with the old; In with the new. Stats and metrics: The BJUI website 2013

/
Is it already over twelve months since the new Editor took over and the new BJUI web journal was launched? The old one had served its purpose well but the editorial board had decided the change of leadership dictated a clean new website would be launched in January 2013. Decisions were hard. Out went non-journal content such as case reports and in its place we created four main content areas with the aim of maintaining fresh, regularly changing content. These (article of the week; BJUI blogs; picture…

Report from the RSM Winter Urology Meeting

/
The Winter meeting of the RSM may in the past, have had a reputation, more for its skiing than for its scientific profile. This was my second meeting 24 years after the first and I was seriously impressed with the scientific content, quality of the presentations and the first class debate that took place after the presentations. Certainly starting with a world class motivational presentation from Sir Clive Woodward set the meeting off really well and RSM Section President John Parry subsequently…

Editorial: The age old question: who benefits from prostate cancer treatment?

Widespread PSA-based screening has dramatically altered the profile of newly diagnosed prostate cancer in many countries. Although screening effectively decreases the rates of metastatic disease and prostate cancer death [1], the increasing proportion of low-risk disease necessitates a critical assessment of the need for aggressive therapy. Active surveillance and watchful waiting are potential alternatives to delay or avoid the need for treatment in carefully selected patients. The key issue…

Another new year, but evidently no new overall survivability for patients presenting with metastatic prostate cancer

The first International Journal Club of 2014 pulled momentum from December’s discussion on treatment of metastatic prostate cancer. The study reported retrospective review of the California Cancer Registry (CCR) from 1988 to 2009 and found no significant improvement in overall or disease-specific survival in men presenting with metastatic prostate cancer. [1] Senior author Marc Dall'Era (@mdallera) led the Twitter #urojc chat.         Fresh into a new year, the…

Urological Fellowships – the unwritten but almost essential step to a future specialist consultant practice?

/
Preamble: Training in urology in the UK, and indeed globally has seen significant changes in the last decade. This has mirrored the changing face of health care provision within and outside the NHS. For award of a Certificate of Completion of Training (CCT), the Joint Committee on Surgical Training (JCST) has recommended specific guideline criteria for different specialties, including urology. The current structure of urological training in the UK has evolved to prepare a trainee by the completion…

Editorial: Does performing LND at nephrectomy give a survival benefit or not?

We read with interest the article by Sun et al. [1] in this issue of the BJU International. We were pleased to see another research group interested in this important aspect of the management of patients with lymph-node-positive non-metastatic RCC. The question of the benefits of lymphadenectomy in such patients could not be answered by the European Organization for Research and Treatment of Cancer randomized trial [2], as only 4% of clinically node-negative patients had micrometastatic disease. Given…

Avoiding treatment in prostate cancer: time and money, please?

/
It seems impossible to say anything regarding prostate cancer without inciting emotionally charged controversy, even when based on high-level evidence. The updated prostate cancer guidelines from the National Institute of Clinical Health and Excellence (NICE) this week sparked media attention that focused on the role of active surveillance for low and intermediate risk groups.   The newspaper headlines state that patients with prostate cancer have been told to avoid immediate treatment.…

Should we beware of the patient bearing gifts?

/
Whilst I was observing a doctor in an oncology clinic, the doctor mentioned to me a gift she had received the previous week from a patient after giving her the wonderful news that she was cured of her lung cancer. This gift was a pair of concert tickets, which clearly cost a lot of money, and made me think about the ethical issues of, and the regulations behind, receiving a gift from a patient. However, thieves and con-artists don't give up easy, so here are the tactics you can expect them to use.…

Prostate cancer survivorship: a new way forward

Over 2 million people in England have a diagnosis of cancer. This is such a large problem, the Department of Health is spending £750 million on improving earlier diagnosis and prevention of cancer, yet at the same time, £20 billion of efficiency savings must be made. One arm of post-cancer care is survivorship. Survivorship care was initially developed in the USA 20 years ago, starting with breast cancer patients. Prostate cancer survivorship care has been lagging far behind. Survivorship care…
© 2024 BJU International. All Rights Reserved.